Utilisations des molécules mutantes solubles CTLA4
- 专利权人:
- Bristol-Myers Squibb Company
- 发明人:
- 申请号：
- EP10184596.4
- 公开号：
- EP2281568A3
- 申请日:
- 2001.07.02
- 申请国别(地区):
- EP
- 年份:
- 2013
- 代理人:
- 摘要：
- The present invention relates to soluble CTLA4 mutant molecules for use in treating an immune disorder associated with graft transplant rejection or for use in treating rheumatic disease.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- UTILISATIONS DE MOLÉCULES CTLA4 MUTANTES
- Methods for Treating Immune Disorders Associated with Graft Transplantaton with Soluble CTLA4 Mutant Molecules
- FUSION MOLECULES AND METHODS FOR TREATMENT OF IMMUNE DISEASES
- Fusion molecules and methods for treatment of immune diseases
- METHODS OF TREATING IMMUNE DISEASES IN CONNECTION WITH ORGAN TRANSPLANTATION WITH SOLUBLE, Mutating CTLA4 MOLECULES
